PF3D7_0921000

PF3D7_0921000 (Pf-E2) is the SUMO E2-conjugating enzyme of Plasmodium falciparum, functioning within the parasite's SUMOylation pathway (PMID:26697886). It engages the P. falciparum SUMO E1-activating enzyme through species-specific surface residues distinct from those mediating the human E1–E2 interaction, with defined residues on both the Pf E1 UFD domain and Pf E2 accounting for this selectivity (PMID:26697886). The N-terminus of Pf-E2 further governs SUMO recognition: it drives a unidirectional cross-species selectivity in which Pf-SUMO can interact with human E2 while human SUMO1 fails to engage Pf-E2, and mutating N-terminal Pf-E2 residues to their human counterparts restores electrostatic, π-π, and hydrophobic contacts sufficient for cross-species binding (PMID:35331687). Functionally, the SUMOylation pathway in which Pf-E2 acts as the E2 component plays a protective role during iron-induced oxidative stress in asexual trophozoite-stage parasites (PMID:26697886). Beyond its role in E1 engagement, SUMO recognition, and oxidative-stress protection, the substrate repertoire and downstream targets of Pf-E2 have not been characterized in the available corpus.

1. 2015 High

   It was unknown how the parasite SUMO E2 enzyme is distinguished from its human counterpart; this study established that Pf-E2 engages the Pf SUMO E1-activating enzyme via species-specific surface residues, defining a divergent E1–E2 interface exploitable for selective targeting.

   Evidence X-ray crystallography of the human SUMO E1 UFD–Ubc9 complex, in silico modeling of Pf counterparts, site-directed mutagenesis, and in vitro binding assays

   PMID:26697886

   Open questions at the time

   • No structure of the actual Pf E1–Pf E2 complex was solved; the Pf interface rests on modeling and mutagenesis
   • SUMO substrates conjugated by Pf-E2 were not identified
   • Catalytic thioester-transfer activity of Pf-E2 was not directly demonstrated
2. 2015 Medium

   The physiological importance of parasite SUMOylation was unclear; perturbation experiments showed the pathway, with Pf-E2 as its E2 component, protects asexual trophozoites against iron-induced oxidative stress, linking the conjugation machinery to a stress-response function.

   Evidence Cell-based exposure of P. falciparum asexual trophozoites to iron-induced oxidative stress with assessment of SUMOylation pathway activity

   PMID:26697886

   Open questions at the time

   • The role is attributed to the SUMOylation pathway broadly rather than to Pf-E2 specifically
   • No direct genetic knockout or knockdown of PF3D7_0921000 was reported
   • The SUMO-modified targets mediating oxidative-stress protection are unidentified
3. 2022 Medium

   It was unknown why Pf and human SUMO systems are not freely interchangeable; this work showed a unidirectional cross-species interaction and mapped the block to N-terminal Pf-E2 residues, defining the structural determinants of SUMO–E2 recognition specificity.

   Evidence Biochemical/biophysical binding assays, site-directed mutagenesis of Pf-E2 N-terminal residues, and electrostatic/interaction modeling

   PMID:35331687

   Open questions at the time

   • Mutagenesis-and-modeling study from a single lab without an experimental co-complex structure
   • Functional consequence of restored cross-species binding for downstream conjugation was not tested
   • Whether N-terminal residues also affect Pf-E2 interaction with the native Pf-SUMO was not resolved

• The substrate repertoire, in-cell essentiality, and catalytic dynamics of Pf-E2 remain unresolved.
• No SUMO substrates conjugated by Pf-E2 have been identified
• No genetic essentiality data for PF3D7_0921000 in the corpus
• No experimental structure of the Pf E1–E2 or Pf E2–SUMO complex